Geron to Present at the J.P. Morgan Healthcare Conference
2013-01-02 22:30:50 -
MENLO PARK, Calif., January 2, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John A. Scarlett, M.D., President and Chief Executive Officer,
will present an overview of the company at 1:00 p.m. Pacific Time on Thursday,
January 10, at the 31st Annual J.P. Morgan Healthcare Conference in San
A live webcast of the audio and slide presentation, including Q&A session, will
be available at
Following the live presentation, the webcast will be archived and available for
replay at the same address for a period of 30 days.
Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat. For more information
about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Geron Corp. via Thomson Reuters ONE